Owen Murray

Owen Murray began working as the Chief Executive Officer for Aprecia Pharmaceuticals in 2023. Prior to that, they held roles at Recordati Rare Diseases Inc., serving as the Vice President of Technical Operations, North America from October 2019 to February 2023, and as the Head of Technical Operations, North America from July 2014 to October 2019.

Owen Murray obtained a Master of Science (MS) degree in Healthcare Leadership from Brown University, acquiring this qualification between 2019 and 2021. In addition, they pursued a Master of Business Administration (MBA) degree in Business Administration and Management, General at Seton Hall University, although the specific timeframe for this degree is not provided. Furthermore, Owen completed a Bachelor of Science (BSc) in Biochemistry from Swansea University; however, the corresponding years of study are undisclosed. Owen also acquired a Finance Certification from the Massachusetts Institute of Technology, with no information available on the duration of this certification. Lastly, Owen attained a Project Management Professional (PMP) certification from the Institute of Project Management, although the exact dates are not specified.